Bruxism and Severity of Temporomandibular Dsyfunction

Sponsor
Bandırma Onyedi Eylül University (Other)
Overall Status
Completed
CT.gov ID
NCT06053723
Collaborator
(none)
91
1
5
18.1

Study Details

Study Description

Brief Summary

The aim of the study was to investigate the effect of bruxism on Temporomanbular joint functionality and dysfunction severity in individuals with Temporomandibular Dysfunction (TMD).

Condition or Disease Intervention/Treatment Phase
  • Other: Fonseca's Anamnestic Questionnaire
  • Other: Numeric Pain Scale
  • Other: Jaw Functionality Limitation Scale-20

Detailed Description

The study included 91 individuals aged 20-55 years with TMD. Participants who volunteered to participate in the study signed the Informed Consent Form and completed the Descriptive Data Form including demographic characteristics. The presence of bruxism in individuals with TMD was questioned and the maximum mouth opening measurement was recorded. TMD severity was assessed by Fonseca's Anamnestic Questionnaire (FAQ), pain severity was assessed by Numeric Pain Scale (NPS), and masticatory and TMJ functioning was assessed by JAW Functional Limitation Scale-20 (JFLS-20). The evaluations of the participants were performed only once.

Study Design

Study Type:
Observational
Actual Enrollment :
91 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
The Effect of Bruxism on Masticatory Functionality and Severity of Temporomandibular Dsyfunction: A Cross-sectional Study
Actual Study Start Date :
Apr 15, 2023
Actual Primary Completion Date :
Sep 1, 2023
Actual Study Completion Date :
Sep 15, 2023

Outcome Measures

Primary Outcome Measures

  1. Bruxism evaluation [April 2023- September 2023]

    Sleep bruxism reported by the individual was recorded. As clinical diagnostic criteria for bruxism; the presence of regular or frequent teeth clenching and grinding sounds followed by pain or fatigue in the jaw muscles on waking up in the morning, temporal headache, masseter muscle hypertrophy, abnormal tooth abrasion and/or jaw locking were questioned and the presence of one or more clinical findings was recorded as bruxism.

  2. Maximum mouth opening [April 2023- September 2023]

    Maximum pain-free mouth opening was measured with a 15 cm ruler

  3. Severity of Temporomandibular dysfunction [April 2023- September 2023]

    Fonseca's Anamnestic Questionnaire (FAQ) was used. The questionnaire includes 10 questions about joint, head and neck pain, pain during masticatory activity, parafunctional habits, decreased joint motion, impaired occlusion and emotional stress. As a result of the questionnaire, the presence of TMD is accepted in patients with a score of 25 and above, and the severity can be classified as mild TMJ disorder (25-45), moderate TMJ disorder (50-65) and severe TMJ disorder (70-100).

  4. Pain intensity [April 2023- September 2023]

    Numeric Pain Scale (NAS): It is a simple, reliable and short-term method commonly used in the clinic to measure pain intensity. The patient is told that the most severe pain he/she feels in the TMJ region is 10, and if there is no pain, the pain intensity is 0. The participant was asked to say a number between 0 and 10 corresponding to the intensity of pain felt in the TMJ region.

  5. Jaw Functionality [April 2023- September 2023]

    Jaw Functionality Limitation Scale-20 was used. It includes a total of 20 items, with "0" indicating no limitation and "10" indicating severe limitation in each item, about the function of the TMJ during different activities, difficulty in chewing and jaw limitation. As a result of the questionnaire, it was reported that TMJ function was limited in individuals with a score of 5 and above.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged between 20 and 55 years,

  • Diagnosed with TMD,

  • volunteer to participate in the study

Exclusion Criteria:
  • having a non-reduced disc problem,

  • surgical operation due to spine, abdomen and/or TMJ problem,

  • trauma, cancer, neurological problems, congenital anomalies, musculoskeletal system problems,

  • systemic disease,

  • facial paralysis

  • Less than 6 months of receiving any treatment related to the spine and TMJ

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bandirma Onyedi Eylul University Balıkesir Turkey

Sponsors and Collaborators

  • Bandırma Onyedi Eylül University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hazel Çelik Güzel, Assist. Prof. Dr, Bandırma Onyedi Eylül University
ClinicalTrials.gov Identifier:
NCT06053723
Other Study ID Numbers:
  • 2023-54
First Posted:
Sep 26, 2023
Last Update Posted:
Sep 29, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hazel Çelik Güzel, Assist. Prof. Dr, Bandırma Onyedi Eylül University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2023